Investors often prefer to invest in shares held by company insiders, as management is typically more aligned with the company’s success and shareholder interests. Currently, insiders own just 22.22% ...

On Tuesday, Recursion Pharmaceuticals Inc (RXRX) stock saw a decline, ending the day at $5.89 which represents a decrease of $-0.11 or -1.83% from the prior close of $6. The stock opened at $5.97 and ...

Buy RXRX near 6.2 target 8.05 stop loss @ 6.18 Details The technical summary data tells us to buy RXRX near 6.2 with an upside target of 8.05. This data also tells us to set a stop loss @ 6.18 to ...

Centaurus Financial Inc. bought a new stake in shares of Recursion Pharmaceuticals, Inc. (NASDAQ:RXRX – Free Report) in the ...

After hours: November 29 at 4:59 PM EST Loading Chart for RXRX ...

Unusual total active option classes on open include: Cabaletta Bio ( CABA ), Core and Main ( CNM ), Recursion Pharmaceuticals ( RXRX ), Fastly Inc ( FSLY ), UP Fintech Holding Ltd ( TIGR ), Hewlett ...

(NASDAQ:RXRX), sold shares of the company's stock, resulting in a total sale value... Recursion Pharmaceuticals, Inc. (NASDAQ:RXRX) Director Blake Borgeson has recently sold a significant amount ...